Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.
| Publicado en: | Psychopharmacology Vol. 221; no. 4; pp. 601 - 611 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |